beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)

Term ID

CHEBI:142155

Synonyms

beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(SO3)-3-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:0)(1-)
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphinganine(1-)
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-sulfo-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
ganglioside SM1a (d18:0)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-) organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-) organic molecular entity Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)

Phenotype where environments contain beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)

Phenotype modified by environments containing beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)

Human Disease Model